论文部分内容阅读
目的:探讨舒利迭和布地奈德对支气管哮喘的疗效差异。方法:收治成人哮喘患者140例,随机分成观察组和对照组,各70例,对照组吸入普米克都保(布地奈德干粉剂)4吸/次,2次/d,观察组在对照组的基础上吸入舒利迭1吸/次,2次/d,两组均连续治疗6周。结果:治疗后,两组患者FEV1、FVC、FEV1/FVC、PEF比较差异有统计学意义(P<0.05);观察组总有效率94.3.0%。对照组总有效率74.3%,两组比较差异有统计学意义(P<0.05)。结论:舒利迭联合布地奈德治疗比单纯应用布地奈德治疗效果显著。
Objective: To investigate the effect of seretide and budesonide on bronchial asthma. Methods: A total of 140 adult asthma patients were randomly divided into observation group and control group, 70 cases in each group. The control group was inhaled Pulmicort® (budesonide dry powder) 4 times a day, twice a day, and the observation group in the control group On the basis of inhaled Seretide 1 suction / time, 2 times / d, two groups were treated for 6 weeks. Results: After treatment, there were significant differences in FEV1, FVC, FEV1 / FVC and PEF between the two groups (P <0.05). The total effective rate in the observation group was 94.3%. The control group, the total effective rate was 74.3%, the difference between the two groups was statistically significant (P <0.05). Conclusion: The combination of seretide and budesonide is more effective than budesonide alone.